Thomas Lund

8PUBLICATIONS
40CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Nanotoxicology, health and safetyMental health nursingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 25, 2026
Digital Symptom Reporting for Treatment Readiness Before Daratumumab: A Blinded Prospective Study in Multiple Myeloma.

|Feb 09, 2026
Identification of Extracellular Vesicle Signatures of Daratumumab Treated Multiple Myeloma.

Kieran Brennan, Katrine F Iversen, Alfonso Blanco-Fernández

|Jun 26, 2025
European Expert Panel Consensus on Outpatient Administration of Teclistamab and Talquetamab in Patients With Multiple Myeloma: Feasibility, Key Considerations, and Future Directions.

Thomas Lund, Cyrus Khandanpour, Sébastien Anguille

|Apr 01, 2025
Home-Based Daratumumab in Patients With Multiple Myeloma.

Tine Rosenberg, Jannie Kirkegaard, Michael Tveden Gundesen

|Dec 09, 2023
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease.

Martin Johansen, Mette Bøegh Levring, Kasper Stokbro

|Mar 27, 2023
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 Study.

Marta Diaz-delCastillo, Michael Tveden Gundesen, Christian Walther Andersen

Pageof 2

Frequent Collaborators

2 joint publications

Marta Diaz-delCastillo

2 joint publications

Michael Tveden Gundesen

2 joint publications

Jannie Kirkegaard

2 joint publications

Jon Thor Asmussen